US equities |
NVDA $186.64 ▲+2.78% MU $690.00 ▲+5.12% AMD $449.04 ▲+11.04% SPCX $134.27 ▲+8.62% AAPL $342.37 ▼-0.52% SNDK $835.06 ▲+3.55% MSFT $530.61 ▼-0.99% TSLA $358.22 ▲+4.23%
FinancialContent

Hua Medicine (OP:HUMDF)

0.3036 UNCHANGED
Last Price Updated: 9:30 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hua Medicine

News headline image
Hua Medicine Announces 2026 Interim Results
From Hua Medicine
Via ACN Newswire
News headline image
Hua Medicine Advances Glucose Homeostasis Platform at ADA 2026, Showcasing Dorzagliatin's Potential Across Metabolic Disease
From Hua Medicine
Via ACN Newswire
News headline image
Hua Medicine Announces 2025 Annual Results
From Hua Medicine
Via ACN Newswire
News headline image
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
From Hua Medicine
Via ACN Newswire
News headline image
Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin
From Hua Medicine
Via ACN Newswire
News headline image
Hua Medicine Announces 2025 Interim Results
From Hua Medicine
Via ACN Newswire
News headline image
Hua Medicine Announces 2024 Annual Results
From Hua Medicine
Via ACN Newswire
News headline image
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters
Via ACN Newswire
News headline image
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'
From Hua Medicine
Via ACN Newswire
News headline image
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis
Via ACN Newswire
News headline image
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce
From Hua Medicine
Via ACN Newswire